Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价松针正脑颗粒治疗偏头痛(瘀血阻络证)有效性和安全性的随机、双盲、安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial to evaluate the efficacy and safety of Songzhen Zhengnao Granule in the treatment of migraine (blood stasis and obstruction syndrome)
探索性评价松针正脑颗粒治疗偏头痛(瘀血阻络证)的有效性和安全性,为确证性临床试验提供依据。
[Translation] To explore the effectiveness and safety of Songzhen Zhengnao Granule in treating migraine (blood stasis and obstruction of collaterals syndrome) and provide a basis for confirmatory clinical trials.
100 Clinical Results associated with Shenzhen Lifu Biotechnology Co., Ltd
0 Patents (Medical) associated with Shenzhen Lifu Biotechnology Co., Ltd
100 Deals associated with Shenzhen Lifu Biotechnology Co., Ltd
100 Translational Medicine associated with Shenzhen Lifu Biotechnology Co., Ltd